Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Dartmouth research points to protein S14 in treating breast cancer

24.08.2006
William Kinlaw, an associate professor of medicine at Dartmouth Medical School, has been working on a protein called S14 since 1990. Over the past few months, however, the news about S14 has picked up. Through a series of recently published academic studies, Kinlaw and his colleagues are ready to pronounce S14 a potential drug target in treating breast cancer.

"Over the past three years, we've learned about S14 and its role in communicating information about the nutrient and energy supply to genes required for fat metabolism in breast cancer cells," says Kinlaw, who is also affiliated with the Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center. "With this knowledge has also come the understanding that most breast cancers have found a mechanism to turn on the S14 gene."

He explains that these tumors are 'addicted' to S14, because it is required for the activation of a group of genes that allow the cancer cells to make fat. Kinlaw and his team have found that breast cancer cells die if S14 is removed, and their analysis of human breast tumors indicates that S14 is critical for metastasis.

"This makes sense, as fat is a crucial fuel for breast cancers," he says. "We believe this is especially so during a tumor cell's attempt to journey from the breast to other parts of the body, because the normal breast tissue supplies machinery that allows tumor cells to acquire fat from the bloodstream. Our data support the hypothesis that once the cells leave this metabolically friendly breast environment, the ability to manufacture their own fat becomes a make-or-break issue."

These findings are supported by three recently published articles. First, a few months ago, Kinlaw and his team published a study in the February 1, 2006, issue of Experimental Cell Research that further explored S14's relationship in driving fat metabolism in breast cancer cells. The researchers discovered that if you inactivate this protein, the cancer cells die. Because of this, Kinlaw explains, S14 may be a new anticancer target for breast cancer patients.

Second, in the July 2006 issue of Breast Cancer Research and Treatment, Kinlaw and fellow Dartmouth researchers Bernard Cole, Peter Morganelli, Gary Schwartz, and Wendy Wells published a study that connected the amount of S14 present in a given clinical breast cancer case to the prediction, with surprising accuracy, of which tumors would recur on long-term follow up. The researchers used a special new antibody made at Norris Cotton Cancer Center in their predictions. Kinlaw says that this study revealed the potential of S14 as a new marker for prognosis in breast cancer, and experiments are now underway to validate this result. Kinlaw has also tapped into the expertise at Dartmouth's Tuck School of Business, where students formulated this idea as a model business plan for a class project for Gregg Fairbrothers, adjunct professor of business administration and the director of the Dartmouth Entrepreneurial Network.

And finally, the journal Endocrinology invited Kinlaw and colleagues to review the topic of fat metabolism in breast cancer cells. In the review, which was available online on June 29, the researchers present a new theory of breast cancer metastasis and its relationship to fat metabolism and diet that focuses on S14.

"We're now working to examine this idea rigorously in cancer-prone mice engineered to lack S14 in the mammary gland, and to find areas on the S14 protein that might be suitable for attack with a drug," says Kinlaw.

Kinlaw's work is supported by funding from the National Institutes of Health and the Department of Defense.

Sue Knapp | EurekAlert!
Further information:
http://www.Dartmouth.edu

More articles from Health and Medicine:

nachricht New malaria analysis method reveals disease severity in minutes
14.08.2017 | University of British Columbia

nachricht New type of blood cells work as indicators of autoimmunity
14.08.2017 | Instituto de Medicina Molecular

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

Im Focus: Scientists improve forecast of increasing hazard on Ecuadorian volcano

Researchers from the University of Miami (UM) Rosenstiel School of Marine and Atmospheric Science, the Italian Space Agency (ASI), and the Instituto Geofisico--Escuela Politecnica Nacional (IGEPN) of Ecuador, showed an increasing volcanic danger on Cotopaxi in Ecuador using a powerful technique known as Interferometric Synthetic Aperture Radar (InSAR).

The Andes region in which Cotopaxi volcano is located is known to contain some of the world's most serious volcanic hazard. A mid- to large-size eruption has...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

New thruster design increases efficiency for future spaceflight

16.08.2017 | Physics and Astronomy

Transporting spin: A graphene and boron nitride heterostructure creates large spin signals

16.08.2017 | Materials Sciences

A new method for the 3-D printing of living tissues

16.08.2017 | Interdisciplinary Research

VideoLinks
B2B-VideoLinks
More VideoLinks >>>